IL33 and chronic obstructive pulmonary disease: Interleukin-33 (IL-33) is another member of the Interleukin-1 family of cytokines that has emerged as a target of interest in a variety of inflammatory conditions including asthma, chronic obstructive pulmonary disease, and most recently Coronavirus disease 2019 (COVID-19) [3–5].